0001213900-26-050191
SEC filingNano-X Imaging reported $13.0M in revenue for FY2025, up 15.4% year-over-year, but deepened operating and net losses amid ongoing strategic restructuring — a deliberate shift toward outsourced manufacturing and cost discipline that widened cash outflows and intensified liquidity pressure.
Management explicitly confirmed in Item 7 that the Company is restructuring its manufacturing footprint to improve gross margins, reduce capital expenditures, and enhance operational efficiency. This initiative directly informs the widening of operating and net losses — operating income declined 37.9% YoY to -$78.2M, and net income fell 40.2% to -$75.0M. These outcomes are not anomalies but expected consequences of a deliberate, multi-year transition, as underscored by repeated references across Items 7 and 8 to outsourcing as a core lever for long-term margin improvement.
Net cash used in operating activities reached -$40.8M, and after $4.2M in capital expenditures, free cash flow totaled -$45.0M. Critically, management states in Item 7 that cash and cash equivalents as of December 31, 2025, will not be sufficient to support operations for at least one year under current plans. This is not forward-looking speculation but an explicit going-concern assessment — a material liquidity risk requiring near-term capital action.